0001209191-20-056066.txt : 20201028
0001209191-20-056066.hdr.sgml : 20201028
20201028141225
ACCESSION NUMBER: 0001209191-20-056066
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201026
FILED AS OF DATE: 20201028
DATE AS OF CHANGE: 20201028
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schoenberg Mark
CENTRAL INDEX KEY: 0001763581
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 201267795
MAIL ADDRESS:
STREET 1: C/O UROGEN PHARMA LTD.
STREET 2: 9 HA TA ASIYA STREET
CITY: RA ANANA
STATE: L3
ZIP: 4365007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-26
0
0001668243
UroGen Pharma Ltd.
URGN
0001763581
Schoenberg Mark
400 ALEXANDER PARK DRIVE
PRINCETON
NJ
08540
0
1
0
0
Chief Medical Officer
Ordinary Shares
2020-10-26
4
M
0
208
A
19444
D
Ordinary Shares
2020-10-26
4
S
0
101
20.9461
D
19343
D
Restricted Stock Units
2020-10-26
4
M
0
208
0.00
D
Ordinary Shares
208
1042
D
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 2,500 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter.
/s/ Jason Smith, Attorney-in-Fact
2020-10-28